NRT Smoking Cessation Aids in Taiwan

  • ID: 222007
  • Report
  • Region: Taiwan
  • 19 Pages
  • Euromonitor International
1 of 5

FEATURED COMPANIES

  • Amway Taiwan Co. Ltd.
  • Cerbos (Taiwan) Ltd.
  • U Chu Pharm Co. Ltd.
  • MORE
New laws prohibiting smoking in indoor public areas came into effect in Taiwan during 2009. Since then, the numbers of people quitting smoking have increased at a faster pace than ever before and one of the main reasons for this is the inconvenience that the public smoking ban means for them. However, many smokers attempted to quit but failed and these were generally lifelong heavy smokers who may be reluctant to attempt quitting smoking again.

The NRT Smoking Cessation Aids in Taiwan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2013-2017, allowing you to identify the sectors driving growth. Forecasts to 2022 illustrate how the market is set to change.

Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the NRT Smoking Cessation Aids market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Amway Taiwan Co. Ltd.
  • Cerbos (Taiwan) Ltd.
  • U Chu Pharm Co. Ltd.
  • MORE
NRT SMOKING CESSATION AIDS IN TAIWAN

List of Contents and Tables
  • Headlines
  • Prospects
  • Progressive Anti-smoking Laws Set To Continue Encouraging Many Smokers To Quit
  • Slumping Sales Due To Fewer Smokers Overall and Fewer Smokers Wanting To Quit
  • the Availability of Subsidised Nrt Smoking Cessation Aids Through Institutional Channels Set To Continue Harming OTC Sales
  • Competitive Landscape
  • Johnson & Johnson Dominates A Consolidated Field of Just Three Players
  • Competition Remains Limited Among A Very Consolidated Field of Just Three Players
  • Falling Smoking Prevalence and the Availability of Subsidised Nrt Likely To Discourage New Entrants
  • Category Indicators
  • Table 1 Number of Smokers by Gender 2012-2017
  • Category Data
  • Table 2 Sales of NRT Smoking Cessation Aids by Category: Value 2012-2017
  • Table 3 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2012-2017
  • Table 4 Sales of NRT Gum by Flavour: % Value 2012-2017
  • Table 5 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2013-2017
  • Table 6 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2014-2017
  • Table 7 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2017-2022
  • Table 8 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2017-2022
  • Executive Summary
  • Pending OTC Switches Remain in the Pipeline Due To Medical Community Opposition
  • Increasingly Busy Urban Lifestyles Continue To Impact Sales in Consumer Health
  • Drugstores/parapharmacies Private Label Lines Compete Against International Brands
  • the Leading Distribution Channels Underline Their Strength With Positive Growth
  • the Rise of Self-medication Set To Bolster Growth Rates in OTC Consumer Health
  • Market Indicators
  • Table 9 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
  • Table 10 Life Expectancy at Birth 2012-2017
  • Market Data
  • Table 11 Sales of Consumer Health by Category: Value 2012-2017
  • Table 12 Sales of Consumer Health by Category: % Value Growth 2012-2017
  • Table 13 NBO Company Shares of Consumer Health: % Value 2013-2017
  • Table 14 LBN Brand Shares of Consumer Health: % Value 2014-2017
  • Table 15 Penetration of Private Label in Consumer Health by Category: % Value 2012-2017
  • Table 16 Distribution of Consumer Health by Format: % Value 2012-2017
  • Table 17 Distribution of Consumer Health by Format and Category: % Value 2017
  • Table 18 Forecast Sales of Consumer Health by Category: Value 2017-2022
  • Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022
  • Appendix
  • OTC Registration and Classification
  • Vitamins and Dietary Supplements Registration and Classification
  • Self-medication/self-care and Preventive Medicine
  • Switches
  • Sources
  • Summary 1 Research Sources
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
- Amway Taiwan Co. Ltd.
- Cerbos (Taiwan) Ltd.
- Sanyo Pharmaceutical Co. Ltd.
- U Chu Pharm Co. Ltd.
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll